Address
Email address
Phone number
Website
https://pharmaestica.eePharmaEstica Manufacturing OÜ - Kaasaegsete ravimivormide tootminePharmaEstica Manufacturing OÜ peamine eesmärk on täistsükliga ravimeid ja bioloogiliselt tõhusate, kvaliteetsete ravimite väljatöötamine ja tootmine.
Name
PharmaEstica Manufacturing OÜ
Registry code
10264929
VAT number
EE100541508
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.09.1997 (27)
Financial year
01.01-31.12
Capital
220 100.00 €
Activity
72111 - Research and experimental development on biotechnology 21201 - Manufacture of pharmaceutical preparations
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Oleg Adamchuk
| 50% - 110 050.00 EUR | Board member | - | |
| Nikita Fedonkin
| 50% - 110 050.00 EUR | - | - | |
| Vadim Zubarev
| - | Board member | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 413 848.11 € | 33 719.05 € | 34 749.2 € | 25 |
| 2024 Q3 | 335 851.09 € | 78 238.31 € | 82 472.81 € | 24 |
| 2024 Q2 | 813 818.21 € | 90 863.6 € | 94 293.05 € | 26 |
| 2024 Q1 | 310 931.53 € | 56 533.08 € | 60 038.53 € | 25 |
| 2023 Q4 | 271 860.2 € | 66 124.15 € | 69 115.66 € | 25 |
| 2023 Q3 | 209 988.75 € | 83 783.8 € | 88 169.74 € | 23 |
| 2023 Q2 | 172 463.5 € | 86 062.52 € | 88 651.71 € | 26 |
| 2023 Q1 | 225 674.97 € | 54 363.23 € | 57 733.12 € | 26 |
| 2022 Q4 | 423 663.79 € | 67 364.41 € | 70 020.2 € | 28 |
| 2022 Q3 | 315 566.85 € | 75 013.03 € | 79 033.41 € | 27 |
| 2022 Q2 | 209 958.93 € | 67 254.05 € | 70 031.66 € | 27 |
| 2022 Q1 | 41 100 € | 57 154.37 € | 61 281.43 € | 26 |
| 2021 Q4 | 144 317.88 € | 79 121.33 € | 81 160.79 € | 26 |
| 2021 Q3 | 185 688.26 € | 133 191.05 € | 137 347.13 € | 29 |
| 2021 Q2 | 511 677.1 € | 72 009.56 € | 76 091.15 € | 33 |
| 2021 Q1 | 460 822.35 € | 112 826.38 € | 117 633.63 € | 35 |
| 2020 Q4 | 256 088.82 € | 133 825.57 € | 136 646.48 € | 35 |
| 2020 Q3 | 90 535.26 € | 118 334.07 € | 123 890.25 € | 32 |
| 2020 Q2 | 16 027.45 € | 96 394.35 € | 99 758.22 € | 34 |
| 2020 Q1 | 288 604.7 € | 84 304.79 € | 85 761.94 € | 34 |
